| WHAT GOT YOU INTERESTED IN EPILEPSY RESEARCH?
I had not originally planned to study epilepsy. During a research project in graduate school, I had the opportunity to work directly with epilepsy patients who were undergoing surgical implantation of depth electrodes to locate their seizure focus. This gave me a chance to interact with patients and become personally connected with how their lives were affected by the disease. One patient I had worked with and grown close to over the course of a month, experienced a tonic-clonic seizure in front of me. This experience deeply impacted me and has inspired my research since.
| EXPLAIN FOR OUR GENERAL READERSHIP WHAT QUESTION YOUR STUDY ADDRESSED AND HOW DID YOU GO ABOUT DESIGNING YOU STUDY?
We created an animal model to determine the impact of patient nonadherence of prescribed antiseizure drugs on seizure control. Although the clinical study of nonadherence has been researched for some time, this is the first time it was modeled in animals. This makes it possible to answer questions about the practice of nonadherence, which would be unethical or impossible to do in humans. This study was enabled by my combined engineering and biological background, as I was able to implement a system that allowed for variable dosing using a drug-in-food model.
| WHAT WERE THE RESULTS

AND HOW DO YOU INTERPRET YOUR FINDINGS?
The practice of nonadherence, as outlined in our model, resulted in such poor seizure control that seizure frequency in the nonadherence group was similar to that of the medication-free group. Thus, it is of paramount importance to the patient that we, as a research community, consider the reality that patients are frequently nonadherent to their prescribed medication. It is my opinion that if we acknowledge that patients will not always take their medication as prescribed, this practice of nonadherence will be incorporated into epilepsy research design, beginning from preclinical stages of drug development and progressing beyond to the clinical treatment of patients. It also must be included during the analysis of the efficacy of treatment.
In addition, another graduate student has taken up this work, and has continued to use this newly established model to answer new, deeper questions about how epilepsy is affected in the presence of nonadherence. We are working together on another manuscript, and hope to see it in press soon!
| WHAT NEXT STEPS IN EPILEPSY RESEARCH ARE YOU TAKING AND WHAT ARE YOUR CAREER GOALS?
I am currently developing my automated feeding system, used in this manuscript, to establish a chronic model for testing the efficacy of novel antiseizure compounds. We hypothesized that this approach will be translationally relevant to the human patient's condition and will allow us here at the ADD program to create a better model for the screening of investigational compounds. I hope this model helps differentiate the next generation of antiseizure therapeutics, and the data generated from this model inspire these new therapies to be pushed forward into clinical trials. I hope to continue to progress in the field of epilepsy research by developing innovative new drug delivery models that demonstrate translational relevance to better allow for screening compounds in the future. 
